TargetRibosomal protein S6 kinase alpha-1(Homo sapiens (Human))
Vertex Pharmaceuticals (Europe) Ltd.
Curated by ChEMBL
Vertex Pharmaceuticals (Europe) Ltd.
Curated by ChEMBL
Affinity DataKi: >1.00E+3nMAssay Description:Inhibition of RSK1More data for this Ligand-Target Pair
TargetRibosomal protein S6 kinase alpha-1(Homo sapiens (Human))
Vertex Pharmaceuticals (Europe) Ltd.
Curated by ChEMBL
Vertex Pharmaceuticals (Europe) Ltd.
Curated by ChEMBL
Affinity DataKi: >2.00E+3nMAssay Description:Inhibition of RSK1 (unknown origin)More data for this Ligand-Target Pair
TargetRibosomal protein S6 kinase alpha-1(Homo sapiens (Human))
Vertex Pharmaceuticals (Europe) Ltd.
Curated by ChEMBL
Vertex Pharmaceuticals (Europe) Ltd.
Curated by ChEMBL
Affinity DataKi: >2.00E+3nMAssay Description:Inhibition of RSK1 (unknown origin)More data for this Ligand-Target Pair
TargetRibosomal protein S6 kinase alpha-1(Homo sapiens (Human))
Vertex Pharmaceuticals (Europe) Ltd.
Curated by ChEMBL
Vertex Pharmaceuticals (Europe) Ltd.
Curated by ChEMBL
Affinity DataKi: 4.30E+4nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
TargetRibosomal protein S6 kinase alpha-1(Homo sapiens (Human))
Vertex Pharmaceuticals (Europe) Ltd.
Curated by ChEMBL
Vertex Pharmaceuticals (Europe) Ltd.
Curated by ChEMBL
Affinity DataKi: 1.40E+5nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
TargetRibosomal protein S6 kinase alpha-1(Homo sapiens (Human))
Vertex Pharmaceuticals (Europe) Ltd.
Curated by ChEMBL
Vertex Pharmaceuticals (Europe) Ltd.
Curated by ChEMBL
Affinity DataKi: 1.70E+5nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
TargetRibosomal protein S6 kinase alpha-1(Homo sapiens (Human))
Vertex Pharmaceuticals (Europe) Ltd.
Curated by ChEMBL
Vertex Pharmaceuticals (Europe) Ltd.
Curated by ChEMBL
Affinity DataKi: 1.80E+5nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
TargetRibosomal protein S6 kinase alpha-1(Homo sapiens (Human))
Vertex Pharmaceuticals (Europe) Ltd.
Curated by ChEMBL
Vertex Pharmaceuticals (Europe) Ltd.
Curated by ChEMBL
Affinity DataKi: 3.20E+5nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
TargetRibosomal protein S6 kinase alpha-1(Homo sapiens (Human))
Vertex Pharmaceuticals (Europe) Ltd.
Curated by ChEMBL
Vertex Pharmaceuticals (Europe) Ltd.
Curated by ChEMBL
Affinity DataKi: 4.00E+5nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
TargetRibosomal protein S6 kinase alpha-1(Homo sapiens (Human))
Vertex Pharmaceuticals (Europe) Ltd.
Curated by ChEMBL
Vertex Pharmaceuticals (Europe) Ltd.
Curated by ChEMBL
Affinity DataKi: 4.00E+5nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
TargetRibosomal protein S6 kinase alpha-1(Homo sapiens (Human))
Vertex Pharmaceuticals (Europe) Ltd.
Curated by ChEMBL
Vertex Pharmaceuticals (Europe) Ltd.
Curated by ChEMBL
Affinity DataKi: 4.50E+5nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
TargetRibosomal protein S6 kinase alpha-1(Homo sapiens (Human))
Vertex Pharmaceuticals (Europe) Ltd.
Curated by ChEMBL
Vertex Pharmaceuticals (Europe) Ltd.
Curated by ChEMBL
Affinity DataKi: 6.90E+5nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
TargetRibosomal protein S6 kinase alpha-1(Homo sapiens (Human))
Vertex Pharmaceuticals (Europe) Ltd.
Curated by ChEMBL
Vertex Pharmaceuticals (Europe) Ltd.
Curated by ChEMBL
Affinity DataKi: 7.20E+5nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
TargetRibosomal protein S6 kinase alpha-1(Homo sapiens (Human))
Vertex Pharmaceuticals (Europe) Ltd.
Curated by ChEMBL
Vertex Pharmaceuticals (Europe) Ltd.
Curated by ChEMBL
Affinity DataKi: 1.20E+6nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
TargetRibosomal protein S6 kinase alpha-1(Homo sapiens (Human))
Vertex Pharmaceuticals (Europe) Ltd.
Curated by ChEMBL
Vertex Pharmaceuticals (Europe) Ltd.
Curated by ChEMBL
Affinity DataKi: 1.30E+6nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
TargetRibosomal protein S6 kinase alpha-1(Homo sapiens (Human))
Vertex Pharmaceuticals (Europe) Ltd.
Curated by ChEMBL
Vertex Pharmaceuticals (Europe) Ltd.
Curated by ChEMBL
Affinity DataKi: 2.30E+6nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
TargetRibosomal protein S6 kinase alpha-1(Homo sapiens (Human))
Vertex Pharmaceuticals (Europe) Ltd.
Curated by ChEMBL
Vertex Pharmaceuticals (Europe) Ltd.
Curated by ChEMBL
Affinity DataKi: 4.00E+6nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
TargetRibosomal protein S6 kinase alpha-1(Homo sapiens (Human))
Vertex Pharmaceuticals (Europe) Ltd.
Curated by ChEMBL
Vertex Pharmaceuticals (Europe) Ltd.
Curated by ChEMBL
Affinity DataKi: 5.00E+6nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
TargetRibosomal protein S6 kinase alpha-1(Homo sapiens (Human))
Vertex Pharmaceuticals (Europe) Ltd.
Curated by ChEMBL
Vertex Pharmaceuticals (Europe) Ltd.
Curated by ChEMBL
Affinity DataKi: 5.80E+6nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
TargetRibosomal protein S6 kinase alpha-1(Homo sapiens (Human))
Vertex Pharmaceuticals (Europe) Ltd.
Curated by ChEMBL
Vertex Pharmaceuticals (Europe) Ltd.
Curated by ChEMBL
Affinity DataKi: 6.20E+6nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair